on SARTORIUS AG (isin : DE0007165631)
Michael Grosse Appointed as CEO of Sartorius AG
Sartorius AG announced that Dr. Michael Grosse will assume the role of Chief Executive Officer effective July 1, 2025. The decision was made by the company's Supervisory Board and follows the announcement from current CEO Dr. Joachim Kreuzburg. Dr. Kreuzburg, who has led the company for over twenty years, will continue until mid-2025.
Dr. Grosse's appointment is part of the strategic leadership transition at Sartorius AG. The company noted that while these plans signal future directions, they are subject to uncertainties due to assumptions underlying them. The official German announcement remains the legally binding reference.
The incoming CEO brings a wealth of experience and is expected to drive the company forward over the next three years. Sartorius AG is a major player in the biopharmaceutical market, listed on major indices such as DAX and TecDAX.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS AG news